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ABSTRACT
Gene set analysis (GSA) is used to elucidate
genome-wide data, in particular transcriptome
data. A multitude of methods have been proposed
for this step of the analysis, and many of them have
been compared and evaluated. Unfortunately, there
is no consolidated opinion regarding what methods
should be preferred, and the variety of available GSA
software and implementations pose a difficulty for
the end-user who wants to try out different
methods. To address this, we have developed the
R package Piano that collects a range of GSA
methods into the same system, for the benefit of
the end-user. Further on we refine the GSA
workflow by using modifications of the gene-level
statistics. This enables us to divide the resulting
gene set P-values into three classes, describing dif-
ferent aspects of gene expression directionality at
gene set level. We use our fully implemented
workflow to investigate the impact of the individual
components of GSA by using microarray and
RNA-seq data. The results show that the evaluated
methods are globally similar and the major separ-
ation correlates well with our defined directionality
classes. As a consequence of this, we suggest to
use a consensus scoring approach, based on
multiple GSA runs. In combination with the direc-
tionality classes, this constitutes a more thorough
basis for an enriched biological interpretation.
INTRODUCTION
The analysis of genome-wide expression data typically
involves the task of compiling a list of the statistical
signiﬁcance of all genes over multiple conditions,
enabling the identiﬁcation of differentially expressed
genes. A number of techniques and methods have been
developed for this step of the gene expression analysis,
but arriving at a list of signiﬁcant genes, however, does
not alone necessarily facilitate the biological interpretation
of the data. To manually go through a list of individual
genes in an attempt to map gene regulation to metabolic
and biological functions and pathways is by far a simple
task. To overcome this, methods based on statistical hy-
pothesis tests have been developed that shift the analysis
from individual genes to sets of genes. Gene set analysis
(GSA), also generally referred to as gene set enrichment
analysis (1–3) or gene set testing (4), has the advantage of
incorporating existing biological knowledge into the ex-
pression analysis. As an example of a common
approach, Gene Ontology (GO) terms (5) can be used to
deﬁne gene sets, thus enabling the identiﬁcation of, e.g.
statistically signiﬁcant biological processes, through the
use of GSA. Gene sets are not restricted to GO terms,
as they can be deﬁned in an unlimited number of ways,
correlating to anything from metabolic or signaling path-
ways to transcription factors and chromosomal positions:
it is up to the researcher to use relevant gene sets for the
question at hand.
The variety of GSA methods available can roughly be
divided into three groups. First, a classic approach is to
use a contingency table to test whether a gene set is
overrepresented by a predeﬁned list of signiﬁcant genes,
e.g. using Fisher’s exact test, the 2 test or the
hypergeometric test. These methods are popular among
GO-based tools (6), including BiNGO (7), DAVID (8),
GOstat (9) and GOEAST (10). A major drawback of
this approach is the requirement of an a priori cut-off of
gene signiﬁcance. Second, a number of methods do not
start from a gene list, but rather from the raw expression
data using multivariate and global tests. Examples include
Goeman’s global test (11), Hotelling’s T2 (12), ANCOVA
(13,14) and MANOVA (15). Third, a large group of the
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GSA methods start from a list of gene-level statistics and,
based on these statistics, calculate a gene set statistic for
each gene set being analyzed. The popular gene set enrich-
ment analysis (GSEA), ﬁrst introduced by Mootha et al.
(16) and subsequently improved and implemented by
Subramanian et al. (17), is an example of such a method.
The third group of methods will be the focus of this
article, for several reasons. Unlike the ﬁrst group of
methods, this approach does not require any a priori sig-
niﬁcance cut-off. Further on, by starting from user-deﬁned
gene-level statistics, these methods are not limited to a
speciﬁc type of data. Microarray (continuous) as well as
RNA-seq (discrete) data can be used for the analysis.
Although we use gene expression throughout this article,
it is also possible to base the gene-level statistics on
genome-wide association studies [see, e.g. (18)], prote-
omics or metabolomics data, further increasing the
ﬂexibility of these GSA methods.
Several authors have reviewed and compared many of
the available GSA methods (1–4,19–23); however, most of
the articles only consider a handful of the methods at a
time. Unfortunately for the end-user, although some rec-
ommendations exist, there is no uniﬁed opinion regarding
what methods perform the best. Partly, this is perhaps
because of the lack of a gold standard. Huang et al. (23)
even suggest that, for the best results, the user should try
multiple GSA tools, even those with similar statistical
approaches, as different implementations may affect the
results. Although a valid point, this procedure is far from
practical for the general research community, as the vast
amount of available tools, partly overlapping in terms of
statistical methods, are implemented on a range of differ-
ent platforms and programming languages, requiring the
user to have high computer and programming skills, as
well as plenty of time.
Ackermann and Strimmer (3) provide a modular frame-
work that describes the key steps of GSA, where one im-
portant step is assessing the signiﬁcance of each gene set.
A common way to do this is to estimate the background
distributions of the gene set statistics either by
randomizing the genes or the sample labels. Here as
well, the literature is unclear on the best procedure. For
instance, Li et al. (24) prefer randomizing the genes,
Goeman and Bu¨hlmann (4) suggest randomizing the
sample labels, whereas Nam and Kim (19) recommend
using both approaches if possible.
After successfully assessing the signiﬁcance of all gene
sets, one is faced with the task of interpreting the GSA
results. The meaning of the gene set P-values depends on
the null hypothesis, which differs between methods and is
connected to the choice of gene set statistic as well as the
signiﬁcance assessment method. This has previously been
discussed by several authors (3,4,19,25), and Goeman and
Bu¨hlmann (4) introduced the distinction between competi-
tive and self-contained tests. A competitive test identiﬁes
gene sets that are signiﬁcantly affected by differential ex-
pression compared with the rest of the genes. On the other
hand, a self-contained test considers only the genes in the
gene set, comparing the association of differential expres-
sion to a given phenotype with that of randomly selected
phenotypes. This is relatively clear; however, it is not
always obvious for the user which deﬁnition of ‘differen-
tial expression’ that different methods use. Is it differential
expression in general, without taking the direction of regu-
lation into consideration, or is there a distinction between
up- and downregulation? Further on, will a gene set
affected by both up- and downregulation be cancelled
out, or detected as signiﬁcant? As an example, Hung
et al. (1) suggest using the absolute values of the gene-level
statistics, thus removing the information about the direc-
tion of change. In this case, a statistically signiﬁcant gene
set should be considered affected by differential expression
in general, disregardful of whether the genes in the set are
up- or downregulated. On the other hand, using the
average of the gene-level statistics of a gene set as the
gene set statistics would only detect gene sets that are
affected by differential expression in a distinct direction.
In an attempt to address the practical issues discussed in
the previous paragraphs, we reﬁned the GSA workﬂow
and introduced some new concepts. Our new workﬂow
takes advantage of incorporating multiple GSA
methods, simplifying the comparison of methods as well
as laying the ground for a consensus scoring of gene sets.
Furthermore, we introduce a new concept of handling the
gene-level statistics to divide the resulting gene set P-
values into three directionality classes: non-directional,
mixed-directional and distinct-directional. In combin-
ation, this classiﬁcation of the results can aid the interpret-
ation of the biological meaning of a signiﬁcant gene set.
Our workﬂow is fully implemented as an R package for
the community to use, collecting a range of GSA methods
into the same platform and framework, thus reducing the
required effort of the user to test different GSA methods.
The aim of this article is 3-fold: ﬁrst, to introduce our
new GSA workﬂow, including the handling of gene-level
statistics, directionality classiﬁcation of gene sets and con-
sensus scoring. Second, to compare a range of selected
GSA methods, as well as to investigate the impact of the
individual components of GSA. This is carried out using
microarray as well as RNA-seq data, from both yeast and
human. Third, we wish to demonstrate the beneﬁts
brought into the analysis by consensus scoring and, in
particular, the directionality classiﬁcation of the results.
MATERIALS AND METHODS
In the following text, the separate steps of the GSA
workﬂow will be described, starting with the methods
for calculating gene set statistics, followed by the signiﬁ-
cance estimation. Next, the modiﬁcation of gene-level stat-
istics will be described together with the concept of the
directionality classes, as well as the consensus scoring
approach. Finally, the processing of the data sets used in
this study is described. More details are available in the
Supplementary Methods.
Gene set statistics
Based on literature review, we identiﬁed 11 methods ful-
ﬁlling our criteria, and their deﬁnitions of gene set statis-
tics are used in our workﬂow. These GSA methods take a
list of gene-level statistics as input (e.g. P-values, t-values
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or fold-changes), giving the user free ﬂexibility of the
process of going from raw expression data to assessing
differential expression. Further on, these methods do not
require any a priori cut-off of gene signiﬁcance, thus
making use of all the data. The 11 methods for calculating
gene set statistics are listed next, together with a brief de-
scription (see Supplementary Methods for more details).
Fisher’s combined probability test
Fisher’s combined probability test (26) is a classical
meta-analysis method that combines P-values from
multiple individual statistical tests. The method is based
on the sum of log transformed gene-level P-values. The
signiﬁcance of each Fisher gene set statistic can be
estimated from a 2 distribution or by a permutation
approach, as described in the next section.
Stouffer’s method
Similar to Fisher’s method, Stouffer’s method (27) also
combines P-values, but calculates the gene set statistic
using the inverse normal cumulative distribution
function. The signiﬁcance of a Stouffer gene set statistic
can be estimated using the normal cumulative distribution
function, or by a permutation approach.
Reporter features
The reporter features method was ﬁrst conceptually
described by Patil and Nielsen (28) and generally
extended by Oliveira et al. (29). At its core, the reporter
features method is identical to Stouffer’s method;
however, the gene set statistics are corrected for the back-
ground distribution before signiﬁcance estimation. The
correction is performed by subtracting the mean and
dividing by the standard deviation of randomly calculated
gene set statistics. Once corrected, the signiﬁcance of the
reporter features gene set statistics is calculated in the
same manner as for the Stouffer’s method.
Parametric analysis of gene set enrichment
Kim and Volsky (30) developed parametric analysis of gene
set enrichment (PAGE) as an alternative to the popular
GSEA. The PAGE gene set statistic is based on the mean
of the gene-level statistics of a gene set and corrected for the
background, represented by all gene-level statistics. As for
Stouffer’s method and the reporter features method, the
signiﬁcance of a PAGE gene set statistic can be estimated
from the cumulative normal distribution.
Tail strength
The tail strength method, proposed by Taylor and
Tibshirani (31), is based on the mean of a set of gene-level
P-values. Initially the genes are ranked according to their
signiﬁcance of differential expression, and the ranks are
subsequently used as weights in the calculation of the gene
set statistics. No theoretical null distribution can be used
for the signiﬁcance calculations, as in the previous
methods. Instead, the null distribution is estimated using
a permutation approach.
Wilcoxon rank-sum test
The Wilcoxon rank-sum test is a common choice for a
non-parametric alternative of a signiﬁcance test. The
gene set statistic is calculated based on the sum of the
ranks of the gene-level statistics, and the signiﬁcance can
be estimated from a normal distribution or using a per-
mutation approach. The Wilcoxon rank-sum test is used
for GSA in the popular limma R-package (32).
Gene set enrichment analysis
GSEA (16,17), as mentioned in the ‘Introduction’ section,
is probably one of the most widespread methods for GSA.
It uses a ranked list of gene-level statistics, so that signiﬁ-
cant genes are located at the two ends of the list (based on
direction of differential expression). Next, a running sum
is computed, starting with the ﬁrst statistic and moving to
the last. For each statistic that belongs to the gene set of
interest, the sum is increased, otherwise it is decreased.
The gene set statistic is the maximum deviation from
zero of the running sum. The value that increases the
running sum can be adjusted by a parameter. If the par-
ameter is set to zero, the gene set statistic equals a
Kolmogorov–Smirnov statistic; however, in this article
we set the parameter to one, as recommended by the
GSEA authors.
Mean, median and sum
Apart from the Wilcoxon rank-sum test, the limma
R-package also offers the alternative to simply set the
gene set statistic as the mean of the gene-level statistics,
for the genes belonging to that gene set. Here, we also
include the alternative to use the median or sum of the
gene-level statistics. In all cases, a permutation approach
can be used to estimate the gene set signiﬁcance.
Maxmean statistic
Finally, Efron and Tibshirani (33) propose to use, what
they call the maxmean statistic. This approach separates
the positive and negative gene-level statistics belonging to
a gene set, and for each of the two subsets, it calculates the
absolute sum divided by the total number of genes in the
set. The gene set statistic is then deﬁned as the maximum
of these two numbers. The signiﬁcance, as for all the
previous methods, can be calculated through a permuta-
tion approach. This will be explained in some more detail
in the following section.
Assessing gene set signiﬁcance
Each gene set statistic can be converted into a P-value that
estimates the statistical signiﬁcance of that gene set. By
deﬁnition, the P-value of a gene set statistic is the prob-
ability to observe a new gene set statistic that is equal to or
more extreme than the given gene set statistic. This prob-
ability can be estimated provided a null distribution, i.e.
the probability distribution of the gene set statistic. For 5
of the 11 gene set statistics, theoretical null distributions,
deﬁned by continuous functions, can be used to estimate
the P-values. These approaches are described in the
Supplementary Methods. In all 11 cases, the null distribu-
tions can also be estimated by a permutation approach.
This approach can be performed in two ways, either by
randomizing the genes, referred to as gene sampling, or by
randomizing the sample labels, referred to as sample
permutation.
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Gene sampling is carried out for each gene set
by randomly taking a sample of genes (of the same
number as in the gene set) and recalculating the gene set
statistic. This is repeated a large number of times (e.g.
10 000 times) to give a discrete null distribution. The
gene set P-value is simply the fraction of random gene
set statistics that are equal to or more extreme (in
general larger) than the original gene set statistic. It
follows that the resolution of the gene set P-values
(the number of possible values) is dependent on the
number of permutations used.
Sample permutation is similar to gene sampling;
however, in this case, the original sample labels are
randomized, and all the gene-level statistics, and subse-
quently all the gene set statistics, are recalculated based
on the new labeling. This procedure is also repeated a
large number of times, and the P-values are calculated
in the same way as described for the gene sampling.
The choice of permutation approach is tightly con-
nected to the underlying null hypothesis. When using
gene sampling, the association of a gene set with the
phenotype is compared with the association of the rest
of the genes to the phenotype. This is termed a competitive
null hypothesis. On the other hand, by using sample per-
mutation, the association of a gene set to the phenotype is
compared with its association to random phenotypes. This
is termed a self-contained null hypothesis. For a deeper
understanding of the permutation approaches and the
competitive and self-contained null hypothesis, please
refer to the articles by Tian et al. (25) and Goeman and
Bu¨hlmann (4).
Classifying the results in terms of directionality of gene
expression changes
The result of a GSA is a list of gene set P-values,
indicating the signiﬁcance of each gene set. In this
article, we deﬁne three directionality classes: non-
directional, mixed-directional and distinct-directional.
Depending on the underlying statistical test, the resulting
gene set P-values are assigned to the appropriate class.
The non-directional class contains gene set P-values
where the information about direction of differential ex-
pression is omitted, so that signiﬁcant gene sets can be
interpreted as affected by differential expression in
general. For the mixed-directional class, a gene set can
be signiﬁcantly affected by differentially expressed genes
in either or both directions. Two P-values for each gene
set are reported, one for each direction. In the case of the
mixed-directional class, a gene set can be both signiﬁcantly
affected by up- and downregulation, if it contains two
subsets of genes that are coordinately regulated in
opposite directions. Finally, the distinct-directional class
aims to identify gene sets that are signiﬁcantly affected by
regulation in a distinct direction. Here as well, two
P-values for each gene set are reported, one for each dir-
ection. If a gene set contains signiﬁcantly differentially
expressed genes in both directions, they will cancel out,
and neither of the two distinct-directional P-values will be
signiﬁcant.
Modiﬁcations of gene-level statistics
The type of gene-level statistics and the chosen gene set
statistic takes part in determining what kind of direction-
ality class the analysis results in. Also, by modifying the
gene-level statistics, P-values for different directionality
classes can be calculated. If the gene-level statistics are
P-values, they can be used unmodiﬁed. As they do not
contain any directional information, the resulting gene
set P-values will belong to the non-directional class. It is
also possible to make two subsets of the gene-level statis-
tics according to information on direction of regulation
and run separate runs for each subset. In this case, the
resulting gene set P-values will belong to the mixed-
directional class. Finally, to use all data, but incorporating
the directional information, we propose to perform a
P-value transformation. In this step, the P-values of all
the upregulated genes are scaled between 0 and 0.5, by
dividing by 2. Next, the P-values of all the downregulated
genes are scaled according to 1-p/2, so that they range
between 0.5 and 1, and so that the signiﬁcance order is
swapped. The result will be that the most signiﬁcantly
upregulated genes will have values close to zero, whereas
the most signiﬁcantly downregulated genes will have
values close to one. Running the GSA analysis with the
transformed and scaled P-values will identify gene sets
that are signiﬁcantly affected by distinct upregulation. A
second run, using P-values that are transformed and
scaled in a reverse manner, will identify gene sets that
are signiﬁcantly affected by distinct downregulation.
A similar approach can be taken if the gene-level
statistics are t-values (or similar). By using the absolute
values the directional information can be discarded, and
by subsetting, the mixed-directional class can be
calculated. The t-values naturally contain information
about direction; therefore, no transformation similar to
the one for the gene-level P-values has to be performed.
A more speciﬁc description of which modiﬁcations are
used for each gene set statistic can be found in the
Supplementary Methods.
Consensus scoring of gene sets
By using various combinations of gene-level statistics,
gene set statistics, signiﬁcance estimation methods and dir-
ectionality classes, different unique GSA runs can be per-
formed. Each run will produce a list of gene set P-values
for some or all of the directionality classes. To achieve a
consensus result, the different gene set P-value vectors
belonging to the same class are aggregated to produce a
consensus score for each gene set and class. The aggrega-
tion is based on ranking the gene sets according to their
P-value and using rank aggregation approaches to yield a
consensus score for each gene set. Two simple approaches
are to use either the mean or the median of the ranks of a
given gene set as the consensus score. We also include
classical rank aggregation methods proposed by Borda
(34) and Copeland (35). If multiple gene sets have identical
P-values, they are given the minimum rank, i.e. the
P-values (0.001, 0.002, 0.002, 0.002 and 0.003) would be
given the ranks (1, 2, 2, 2 and 5), as input to the rank
aggregation methods.
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Robustness analysis
To investigate the robustness of the consensus scoring
approach, two analyses were performed. First, the consist-
ency of the consensus scores were evaluated when the input
GSA runs originated from different numbers of gene per-
mutations, i.e. using gene set P-value vectors with different
resolution. Second, the robustness with regard to randomly
selecting different subsets of GSA runs to aggregate was
investigated. The detailed approach of the robustness
analysis is described in the Supplementary Methods.
Data sets and processing
We use two data sets to evaluate the workﬂow. The ﬁrst
data set is the human diabetes microarray data from
Mootha et al. (16), comparing muscle biopsies from 17
normal glucose tolerant men to those from 18 men with
type 2 diabetes. From the authors, we acquired normalized
expression values for the 35 samples and used the R
package limma (36) to ﬁt linear models to each of the
genes to describe the expression levels for the two groups.
Further on, an empirical Bayes approach, as implemented
in the eBayes function, was used to assess differential ex-
pression for each gene between the two groups. The result-
ing t-values, P-values and fold-changes were used in our
gene set analysis. First, we used GO terms as gene sets,
with at least 5 mapped gene-level statistics and at most
1000 mapped gene-level statistics. In this case, 6030 gene
sets passed the size limits, and 17016 of 22 283 gene-level
statistics were mapped to at least one gene set. For the
permutation-based signiﬁcance assessment approaches,
1000 permutations were used. Second, as a case study, we
used the same 149 gene sets that were originally used by
Mootha et al (16). These gene sets include 113 metabolic
pathways and 36 clusters of co-regulated genes. In this case,
9120 gene-level statistics were mapped to at least one gene
set. For the signiﬁcance assessment, 10000 permutations
were used for gene sampling and 1000 permutations for
sample permutation.
The second data set is from a study comparing different
RNA-seq–based transcriptome analyses with each other
as well as with microarrays (37). For this, a case study
was used comparing the transcriptome of Saccharomyces
cerevisiae cultivated under batch conditions and in chemo-
stats. From the authors, we acquired gene-level P-values
and fold-changes for the comparison of the two groups.
These statistics were acquired both from their microarray
analysis and from their RNA-seq analysis. For the latter,
the analysis with Stampy and Cuffdiff was used. For the
microarray-based comparison, we also acquired t-values.
GO terms were used as gene sets, with the same size limits
as stated previously. In this case, 1436 gene sets passed the
size limits, and 5439 of 5662 gene-level statistics were
mapped to at least one gene set. For the gene sampling
approach, 1000 permutations were used.
RESULTS
As outlined in the ‘Introduction’ section, GSA suffers
from some practical issues. In summary, (i) there is no
consolidated opinion regarding which gene set statistics
are to be preferred; (ii) it is unclear whether to use
sample permutation or gene sampling for signiﬁcance as-
sessment and if there is a great difference; (iii) from a
biological point of view, it may not be obvious what a
signiﬁcant gene set means in terms of directionality; and
(iv) the multitude of methods implemented are naturally
spread among different platforms and programming lan-
guages, making it laborious for the average user to test
different methods. To address these issues, we set out to
reﬁne the GSA workﬂow and use this to investigate the
impact of the different components of GSA on the results.
The reﬁned GSA workﬂow
An overview of the reﬁned GSA workﬂow is presented in
Figure 1A. As described in the ‘Materials and Methods’
section, the input to the GSA is gene-level statistics
originating from any statistical test of the user’s choice.
Next, the gene-level statistics are modiﬁed as possible (un-
modiﬁed, absolute values, subsetting and P-value trans-
formation) as described in the ‘Materials and Methods’
section, and one analysis is run for each modiﬁcation.
The purpose of the modiﬁcations is to enable parallel
GSA runs resulting in gene set P-values of different direc-
tionality classes. For each possible modiﬁcation, including
the unmodiﬁed gene-level statistics, a gene set statistic is
calculated according to one of the 11 possible methods.
The signiﬁcance of each gene set statistic is calculated
either by using a theoretical null distribution (if possible
for that statistic) or by a permutation approach (either
gene sampling or sample permutation). The resulting gene
set P-values will belong to one of the three directionality
classes that we introduce in this article (non-directional,
mixed-directional and distinct-directional). Gene sets that
are found to be signiﬁcant in the non-directional class
should be interpreted as affected by differential expression
in general, disregardful of if the direction of regulation
have components of both up- and downregulation. Gene
sets that are found signiﬁcant in the mixed-directional
class are given two P-values, one testing for upregulation
and the other for downregulation. Here, a gene set can be
signiﬁcantly affected by upregulation disregardful of the
extent of downregulation. As a consequence, in the mixed-
directional class, a gene set can be found signiﬁcant in
both the upregulated and downregulated part. Finally,
as a balance, the distinct-directional class detects gene
sets that are signiﬁcantly affected by differential expres-
sion in one distinct direction. A gene set that contains
mainly signiﬁcantly differentially expressed genes, but in
both directions, will not turn up signiﬁcant in this class.
The directionality classiﬁcation is determined by the
type of gene-level statistics and gene set statistics that
are used as well as which modiﬁcation of the gene-level
statistics that is applied. The purpose of the classes is to
aid the user in the interpretation step. By running the GSA
with a combination of settings, it is possible for a gene set
to be assigned P-values in each class, giving more infor-
mation about direction and extent of regulation, than a
single P-value would.
A GSA according to our workﬂow can be depicted as a
unique path through a graph, as in Figure 1B. However,
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not all paths are possible, some restrictions exist
depending on which gene set statistic is used. Figure 1C
summarizes for each type of gene set statistic, which
gene-level statistic it takes, which type of signiﬁcance esti-
mation that is possible to use, and which directionality
classes it is possible to calculate P-values for.
The directionality classiﬁcation clearly separates
the results
We were interested in investigating the importance of the
different steps of GSA and how they inﬂuence the results.
We applied our workﬂow to the human diabetes micro-
array data from Mootha et al. (16), comparing 17 normal
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Figure 1. Overview of the reﬁned GSA workﬂow. (A) The key steps in the workﬂow. Starting from user-deﬁned gene-level statistics, and
their possible modiﬁcations, gene set statistics are calculated according to the 11 available methods. Signiﬁcance of the gene sets is estimated
based on a theoretical null distribution or a permutation approach. The ﬁnal gene set P-values will be separated into the deﬁned directionality
classes, facilitating the interpretation step. (B) A graph representation of our GSA workﬂow. Each path through the graph corresponds to a unique
run of the GSA. The nodes represent the number of settings that can be made at each step. The resulting directionality classes depend on
the combination of settings made. (C) Not all paths, or combinations of settings, are allowed. The table shows which settings are possible for
each gene set statistic method. The highlighted settings correspond to the highlighted path in B and will result in two of the three possible P-value
classes.
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glucose tolerant men to 18 men with type 2 diabetes.
Using GO terms as gene sets, we ran our workﬂow with
all possible combinations of settings (analogous to paths
through the graph), using gene-level P-values and t-values
as input. This resulted in 127 unique runs, and thus 127
unique gene set P-value vectors, each representing the
results from a unique combination of gene-level statistics,
gene set statistic types, signiﬁcance estimation procedures
and directionality classes. By performing principle compo-
nent analysis (PCA) on the 127 vectors, each containing
P-values for 6030 GO gene sets, the impact of the different
components of GSA, on the variance in the resulting
P-values, can be explored. Figure 2A shows a plot of the
two ﬁrst principle components, together explaining 79.7%
of the variance. The main separation of the data seems to
be consistent with our classiﬁcation of P-values, shown by
the ﬁve differently colored clusters. As expected, the runs
testing for upregulated gene sets are separated from the
downregulated ones, and the mixed-directional P-value
class is closer to the non-directional, compared with the
distinct-directional class. The latter is expected because
the mixed-directional class may contain gene sets that
are signiﬁcantly affected by both up- and downregulation.
These sets will also be signiﬁcant if direction of regulation
is disregarded, i.e. the non-directional class, whereas the
gene sets will be non-signiﬁcant in the distinct-directional
class.
To further investigate the data, the directionality class
factor was removed by dividing the 127 P-value vectors
into ﬁve groups according to the clusters and rerunning
the PCA on each of these groups. In Figure 2A, the
smaller PCA plot of the non-directional class shows that
the choice of gene set statistic partly explains the variance
in the data within a class, illustrated by the scattered
groups 1–6 (see Supplementary Figure S1 for the other
classes). We also observe some separation depending on
the choice of gene-level statistics: the mean and sum gene
set statistics are separated into groups 3 and 5, respect-
ively, depending on the gene-level statistic used. The factor
that separates the data the least is the choice of signiﬁ-
cance estimation method (theoretical null distribution,
gene sampling or sample permutation) as displayed by
the black, green and purple boxes within each of the six
scattered groups. Apparently, the choice of method for
signiﬁcance estimation plays a minor role from a global
view.
To complement the principle component analysis, we
also calculated the Spearman correlation for each pair of
the 127 gene set P-value vectors. A heatmap of these
results is shown in Figure 2B (see Supplementary Figure
S2 for detailed row and column labeling). Based on their
correlation, the runs were hierarchically clustered, and
again, the ﬁve main clusters correlate to the directionality
classes. The correlation heatmap also illustrates the
relations between the different classes. The distinct-
directional (up) class shows a strong inverse correlation
to the distinct-directional (down) class and to the
mixed-directional (down) class. The mixed-directional
(up) class does, however, not show an inverse correlation
to the mixed-directional (down) class, which is expected.
Finally, the non-directional class correlates well to the
mixed-directional class, but not to the distinct-directional
class. Again, from a global view, focusing on the ﬁve
larger squares making up the diagonal of the heatmap,
we can conclude that the different GSA runs correlate
well. In particular, we can lift out the correlation of the
results when choosing between gene sampling and sample
permutation. Supplementary Table S1 shows that the cor-
relation between gene sampling and sample permutation
for all GSA methods and directionality classes is very
high. The average correlation is 0.98 and the minimum
correlation, representing the worst case, is 0.96.
To not be constrained by one data set, we also applied
our workﬂow on expression data from a case study
comparing transcriptional differences in S. cerevisiae
when cultivated in batch or chemostat, using both micro-
arrays and RNA-seq (37). This allows us to investigate
how the GSA results are affected by the use of two differ-
ent platforms for assessing gene expression.
First, however, we noted that Fisher’s and Stouffer’s
method, using theoretical null distributions for signiﬁ-
cance assessment, yield remarkably small P-values, in par-
ticular for large gene sets. This is true for the S. cerevisiae
data sets, but not for the human diabetes data set
(Supplementary Figure S3). The distributions of gene-level
P-values of the human diabetes data, the S. cerevisiae
microarray data and the S. cerevisiae RNA-seq data are
compared in Supplementary Figure S4. Fisher’s and
Stouffer’s method will consistently assign higher signiﬁ-
cance to larger gene sets if the gene-level P-value distribu-
tions are skewed towards small values. To illustrate this,
Figure 3A shows boxplots of ﬁve simulated gene-level
P-value distributions with increasing proportion of small
P-values. The distribution of P-values is modeled by a
mixture of the b distribution and the uniform distribution
(38) (see Supplementary Methods for details). Figure 3B
shows scatterplots of the gene set P-values, when using
each of the ﬁve distributions as input, where it is
obvious that Fisher’s and Stouffer’s methods show a
clear dependency to gene set size. This property can be
overcome by using the permutation-based null distribu-
tions in place of the theoretical ones. As the two
S. cerevisiae data sets have P-value distributions that are
similar to the rightmost of the simulated distributions (as
opposed to the human diabetes data, which are similar to
the leftmost distribution), the size-dependency of Fisher’s
and Stouffer’s method will pose a problem. To avoid this,
we simply removed the runs, in which Fisher’s or
Stouffer’s method was used in combination with a theor-
etical null distribution for signiﬁcance estimation before
the continuing analysis.
Once these runs were removed, a PCA was run on the
remaining 128 gene set P-value vectors, containing gene
set P-values for 1436 GO terms. Figure 3C shows a plot of
the ﬁrst two principle components, together explaining
74.1% of the variance. Each point represents a run with
a unique combination of platforms (RNA-seq or micro-
array), gene-level statistics, gene set statistic types, signiﬁ-
cance estimation procedures (theoretical null distribution
or gene permutation) and directionality classes. Even
though microarray and RNA-seq data are mixed, the
results are well in line with those from the human
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diabetes data aforementioned. The runs cluster according
to the directionality classes, although there seems to be a
minor separation of the two platforms within each cluster.
Consensus gene set scores by rank aggregation
Our observations from running the GSA workﬂow for all
combinations of settings, are based on human and yeast
expression data from both microarrays and RNA-seq.
From this we conclude that the resulting gene set P-
values do not vary much between runs with different
settings, in fact they correlate well. From a biological
point of view, in terms of interpreting the top signiﬁcant
gene sets, it is more relevant to use the information given
by the combination of the directionality classes, than
focusing on selecting one method. As a consequence of
these two points, we propose to use all possible runs, or
a larger subset of these, and combine the results for each
directionality class. This means aggregating the informa-
tion given by each of the ﬁve clusters rather than arbitrar-
ily choosing one of the methods to base the biological
interpretation on. The concept is outlined in Figure 4.
To aggregate the results, each gene set P-value vector is
transformed into a rank vector, in total assigning each
gene set with a set of ranks, one for each run. This turns
the aggregation into a ranked voting problem, i.e. the
process of selecting candidates based on ranked lists
from multiple voters (in this case the different runs).
This is not an uncommon problem, typically encountered
during political elections, and thus there exists many
methods to choose among. Naeem et al. (2) suggests
using the average rank as a consensus score, in the case
study provided later in the text, we instead use the median
rank to tolerate outlier bias. In the Piano package, we also
include the options of using the classical consensus
methods proposed by Borda (34) and Copeland (35), re-
spectively (see Supplementary Table S2 for a comparison).
The reason to use the ranks rather than working with the
P-values directly is to give equal weight to conservative
methods (with few low P-values) and less conservative
methods (with many low P-values).
The directionality classiﬁcation enriches the biological
interpretation
As a case study and an example of how the directionality
classiﬁcation and consensus scoring can enrich the biolo-
gical interpretation, we used the human diabetes data set
along with the 149 gene sets that were originally used for
these data by the authors of the GSEA article (16). With
this input we reran our workﬂow, yielding 127 runs. For
each run sharing the same directionality class, the gene
sets were ranked according to their P-values, and these
ranked lists were aggregated using the median rank as a
consensus score. Figure 5A shows boxplots of the gene set
ranks given by each run for the distinct-directional (up)
class (see Supplementary Figure S5 for the other classes),
and the red lines represent the median ranks, i.e. the
A B
Figure 2. (A) A PCA plot of the 127 gene set P-value vectors from different runs of the GSA workﬂow using the human diabetes data. The two ﬁrst
principle components capture 79.7% of the variance. The major separation of the results is consistent with the deﬁned P-value classes. The small plot
shows the ﬁrst two principle components of the 31 non-directional P-value vectors. The choice of gene-level statistic and gene set statistic seems to
have a small importance, shown by the separation into six groups (1: maxmean; 2: Fisher’s method; 3: tail strength, mean of t-values, sum of t-
values; 4: reporter features, Stouffer’s method; 5: Wilcoxon, mean of P-values, sum of P-values; 6: median). The choice of signiﬁcance assessment
method seems to play a minor role to the results. (B) A heatmap of the Spearman correlation of each pair of the 127 gene set P-value vectors. From
a global view, the runs within each P-value class are highly correlated, shown by the ﬁve diagonal squares.
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consensus score for each gene set. Figure 5B shows a
heatmap of the consensus scores of the top-ranked gene
sets for each of the directionality classes. Although the use
of consensus scores will select the most signiﬁcant gene
sets based on all GSA runs, the scores themselves do not
convey the absolute statistical signiﬁcance of those gene
sets. Hence, for one data set or study, a gene set with
consensus score 10 may be highly signiﬁcant, whereas a
gene set with the same score in another data set may be
less signiﬁcant. To complement the consensus scores, we
report the median P-value for each gene set, along with its
consensus score, as a guide for which gene sets that should
be further considered in the biological interpretation
(Supplementary Figure S6). Figure 5C shows the median
gene set P-values plotted against the consensus ranks. The
gene sets in quadrant b are all top-ranked and have a
median P-value <0.05. The few gene sets in quadrant a
are selected among the top-ranked, but they have P-values
slightly >0.05. In principle, for a desired median P-value
as cut-off for signiﬁcance, one wishes to adjust the hori-
zontal line (consensus rank) so that quadrant a contains as
few gene sets as possible.
A
B
C
Figure 3. (A) Boxplots of ﬁve simulated P-value distributions
(log-scaled) with increasing skewedness towards low P-values.
Outliers extending beyond the plot borders are not shown.
(B) Scatterplots of gene set P-values (log-scaled) against gene set size
for Fisher’s and Stouffer’s methods, respectively, based on each of the
ﬁve simulated gene-level P-value distributions. An increasing depend-
ency of gene set size for the rightmost distributions can be observed.
Each point represents the average of 100 random gene sets of the same
size. (C) A PCA plot of the 128 gene set P-value vectors from different
runs of the GSA workﬂow using the S. cerevisiae RNA-seq and micro-
array data. The ﬁrst two principle components explain 74.1% of the
variance. Although a mix of platforms, the major separation of
the results is consistent with our directionality classiﬁcation.
Figure 4. Outline of the concept of result aggregation of the direction-
ality classes. (1) Initially, repeated runs of the GSA workﬂow are per-
formed, resulting in multiple gene set P-value vectors, each representing
a unique combination of settings (gene-level statistic, signiﬁcance esti-
mation method, gene set statistic and directionality class). (2) Based on
their directionality class, the P-value vectors are grouped and converted
to ranks and ﬁnally (3) aggregated classwise. (4) This constitutes a more
thorough basis for the biological interpretation of the gene set results.
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The use of consensus scores and directionality classes
enables us to get a more varied picture of how the gene
sets are affected by differential expression. To explain this,
we will use the three gene sets marked in Figure 5B as
examples. The OXPHOS_HG-U133A_probes gene set
has a consensus score (median rank) of 1 in the non-
directional, mixed-directional (up) and distinct-directional
(up) class. The corresponding median P-values are also
highly signiﬁcant for these classes (Supplementary
Figure S6). This tells us that the gene set is in general
highly regulated, as the non-directional class identiﬁes
gene sets that contain a high amount of signiﬁcant
genes, although not taking direction into account.
Further on, if we are just interested of the part of the
gene set that contains upregulated genes (upregulated in
the normal glucose tolerant group compared with the type
2 diabetes group), we still ﬁnd that this part is signiﬁcantly
differentially expressed (as reported by the mixed-
directional up class). This tells us that there is an import-
ant component of upregulation, even though there could
also be an important component of downregulation sim-
ultaneously. For the OXPHOS_HG-U133A_probes gene
set, this is not the case, as the mixed-directional (down)
class reports a median rank of 61. Finally, the
A B
C
Figure 5. (A) Boxplots of individual ranks for the 149 Mootha gene sets representing metabolic pathways and co-regulated genes (c1–c36). Each box
shows the ranks given in a speciﬁc gene set by the different runs of the GSA workﬂow, for the distinct-directional class (see Supplementary Figure S5
for the other classes). The gene sets are sorted, from top to bottom, based on their median rank, i.e. the consensus score. All outliers are shown as
gray points. The vertically aligned outliers of the bottom ranked gene sets originate from the GSEA runs, which score gene sets with positive and
negative gene set statistics separately. In this case, the negative gene sets are not scored and thus ranked equally and last. (B) A heatmap of the
consensus scores of selected gene sets. All gene sets that received a median rank <10, in at least one class, are included. The three gene sets selected
by a black rectangle are further discussed in the text. Gene sets with median P-values <0.05 are marked with an asterisk, and all corresponding
median gene set P-values are shown in Supplementary Figure S6. (C) For all gene sets and each directionality class, the median P-value over all runs
of the GSA workﬂow is plotted against the consensus rank (y-axis is logarithmic). For a chosen consensus score-based cut-off (horizontal line), one
can observe the corresponding median P-value cut-off (vertical line) that all selected gene sets pass, i.e. for which they all end up in quadrant b. The
P-values that are <1e-10 are set to this value in the plot.
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distinct-directional (up) class tells us that this gene set is
coordinately upregulated (in the normal glucose tolerant
group), all in correlation with the main results of Mootha
et al. (16). Note that a gene set can receive good scores in
the distinct-directional class, of one direction, and still get
a good score in the mixed-directional class, of the other
direction. This only means that, as a whole, the gene set is
regulated in a distinct direction, but it can contain a small
subset of genes that compose a component of regulation
in the opposite direction. This is the case for the
MAP00240_Pyrimidine_metabolism gene set.
The MAP00240_Pyrimidine_metabolism gene set has a
score of 18 for the distinct-directional (up) class, as
compared with 130 for the distinct-directional (down)
class. Naturally, this tells us that the gene set is
coordinately upregulated. However, in the mixed-
directional (down) class the gene set is given a score of
3. Combined, this information tells us that the small
subset of downregulated genes is highly signiﬁcant
(median P-value of 0.0069), but as a whole, the upregula-
tion overrides this downregulated component.
As a third example of the beneﬁts with the directionality
classes, during the interpretation step, we will use the
MAP00910_Nitrogen_metabolism gene set. This gene set
receives a good score in the distinct-directional (down)
class (median rank of 5 and median P-value of 0.0075),
but not in the mixed-directional (down) class or any of the
other classes. This means that the gene set as a whole is
biased towards downregulation. In fact, 22 genes are
downregulated, whereas only 8 are upregulated.
However, as we can see from the mixed-directional
(down) class, the downregulated genes on their own are
not signiﬁcant.
Robustness analysis
The previous section demonstrates the advantages with
the directionality classiﬁcation during the biological inter-
pretation. An important question that remains to be
answered is if the consensus scoring approach is robust,
i.e. if it generates comparable results with regard to what
input it is given. We, therefore, investigated two issues
regarding how consistent the consensus scoring is: ﬁrst
by using runs of the GSA workﬂow with different
numbers of permutations during the P-value calculations
and second by using randomly selected runs.
Starting with the ﬁrst issue, the concern is that when
using a low number of permutations for the gene set
P-value calculations, the resolution of the P-values will
be low, resulting in that several gene sets may share the
exact same P-value. Consequently, these gene sets will
receive the same rank (see Supplementary Figure S7A
for different numbers of permutations) when used as
input to the consensus scoring algorithm. The question
is if such a case would produce similar consensus scores
when compared with the case of using GSA runs with a
high number of permutations as input. To investigate this,
we reran the GSA workﬂow, based on the human diabetes
data with the original Mootha gene sets, for a selection of
methods (Supplementary Methods) using different
numbers of gene permutations (500, 750, 1000, 1500,
2000, 5000 and 10 000). The results from the runs in
each of the seven permutation groups were aggregated
so that each group resulted in a consensus score vector
(actually one for each directionality class) for the gene
sets. These consensus score vectors can be compared by
calculating the Spearman correlation between all possible
pairs, and it turns out that they correlate well. The
minimum pairwise correlation (over all directionality
classes and the four rank aggregation methods) is 0.997,
showing that the correlation is high even in the worst case
(Table 1). Next, we aggregated the runs again, but this
time by randomly choosing methods from the different
permutation groups, so that results that were aggregated
into consensus scores originated from a mix of permuta-
tion numbers. This was repeated 1000 times, each time
using a different random set of runs from the seven
groups. Again, the resulting 1000 consensus score
vectors for each directionality class correlate well
(minimum correlation is 0.998), conﬁrming that the con-
sensus scoring approach is robust and not heavily
inﬂuenced by mixing methods using different numbers of
permutations for signiﬁcance estimation (Table 1).
Regarding the second issue, the concern is that the con-
sensus scores will differ depending on which GSA runs are
chosen to be aggregated. To test this, we used the results
from the case study on the human diabetes data. From
these results, we randomly selected 95% of the GSA runs
as input to the consensus scoring algorithm and repeated
this 1000 times, thus generating 1000 consensus score
vectors for each directionality class. As it turns out, the
correlation of these results is high, and the minimum cor-
relation is 0.994. This approach was also repeated when
randomly using 85 and 70% of the GSA runs, showing
similar results (see Table 1 for details). The robustness
analysis, using 95, 85 and 70% of the runs, was also
performed for the S. cerevisiae data set and the human
diabetes data set with GO terms (Supplementary
Table S3).
All the aforementioned results on robustness are on a
global scale, i.e. comparing all gene sets. In practice, it
may be interesting to also focus on the top-ranked gene
sets and compare these between runs of the consensus
scoring algorithm during the robustness analysis.
Reassuringly, it turns out that the vast majority of the
top-ranked gene sets, i.e. the ones that would be selected
for further biological interpretation, are highly ranked in
all consensus scoring runs, regardless of the input (i.e.
which GSA runs and how many permutations). See
Supplementary Figure S7 for full details.
The Piano R package for enriched gene set analysis
The workﬂow described in this article, as well as the con-
sensus scoring approach, is implemented as the R package
Piano (Platform for Integrated Analysis of Omics data).
Additionally, Piano includes functions for importing gene
set collections of various formats, including the Cytoscape
sif-format, the gmt-ﬁles available from the Molecular
Signatures Database (17) and genome-scale metabolic
models in the SBML-format, e.g. available through the
web-based BioMet ToolBox (39) and the Human
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Metabolic Atlas (40) for microorganisms and human cell
types, respectively. The package contains implementations
of all the gene set statistic methods described in this
article, serving as a good platform for testing different
gene set analyses using the same set-up. The package
also includes several functions for result visualization,
including a network-based plot showing overlapping
gene sets and their signiﬁcance. Finally, Piano also
contains functions for the full analysis of microarray
data, if the user wants a fully integrated GSA starting
from raw expression data. See Supplementary Figure S8
for an overview of the functions in the Piano R package.
Piano is available, together with a user manual, for
download at www.sysbio.se/piano.
DISCUSSION
In this article, we have addressed the practical issues with
gene set analysis based on the questions raised in the
‘Introduction’ section. We have deﬁned a new workﬂow
for GSA where we include a step of using different modi-
ﬁcations of the gene-level statistics. We have also
proposed to separate the GSA results into three classes,
based on the choices made at each step of the analysis,
describing different aspects of gene expression direction-
ality. As our workﬂow is fully implemented in the Piano R
package, it serves well as a platform for testing and
evaluating different GSA runs in a simple way.
However, its major use should be to run repeated
analyses with different settings and use the consensus
scoring approach, and in particular the directionality
classes to interpret the results.
In this study, we initially use the Piano package to
evaluate the impact of the separate components of the
GSA workﬂow. The primary observation is that the dif-
ferent methods produce comparable results. However, it
should be mentioned that the choice of gene-level statistics
as well as gene set statistics do inﬂuence the results to
some extent, although from a global point of view, they
still correlate well. Regarding the three signiﬁcance esti-
mation methods (theoretical null distribution, gene
sampling and sample permutation), we did not observe
any great differences between the results. In particular,
the gene set P-values show a high correlation when
comparing gene sampling with sample permutation. The
lack of great difference between these two signiﬁcance es-
timation methods means that the choice between them
should be based on which is more practical and which is
statistically theoretically correct. However, these two
issues, in particular the latter, need to be further
investigated. From a theoretical point of view, it is of
course important to consider the change of null hypothesis
depending on the choice of signiﬁcance estimation
method, but in general and from a practical point of
view, we prefer using gene sampling. The reason for this
is that permutated null distributions do not rely on the
assumptions that the theoretical null distributions make
on the gene-level statistics. These assumptions may pose
a problem for some gene-level data, as we showed for the
case of Fisher’s and Stouffer’s method. Further on, sample
permutation takes a considerable higher amount of com-
putational time compared with gene sampling, as the step
of recalculating the gene-level statistics has to be included.
Furthermore, to sufﬁciently permute the sample labels to
generate an appropriate background of gene-level statis-
tics, a proper number of samples have to be available. For
small-scale experiments with few replicates, this may often
not be the case.
The similarity of the different methods, or actually, the
different runs of the GSA workﬂow, leads to a difﬁculty in
selecting the best method. Instead, perhaps other factors
will become more guiding, such as availability of software
in a familiar system. As a consequence of this, we propose
to use a combination of methods and use the consensus
scoring approach to ﬁnd important gene sets. This would
normally be a somewhat laborious task but is easily per-
formed with the implementations in Piano. Regarding
runtime, of all the methods implemented, the GSEA and
Wilcoxon rank-sum test take the longest time, up to
several hours if the gene set collection is large. However,
it is possible to run the consensus approach with a
majority of the methods within a reasonable time. As an
example, running the S. cerevisiae microarray data with
1436 GO term gene sets, using all methods except GSEA
and Wilcoxon, takes 15 min on an ordinary desktop
computer. Future efforts should include improving the
implementations of the slower methods with regard to
decreasing the runtime.
Table 1. Robustness of the consensus scoring approach
Robustness analysis Mean rank Median rank Borda Copeland
Different number of permutations 0.998 0.997 0.998 0.998
Mixed number of permutations 0.999 0.998 0.998 0.998
95% of the GSA runs 0.997 0.994 0.997 0.997
85% of the GSA runs 0.991 0.978 0.991 0.991
70% of the GSA runs 0.978 0.968 0.979 0.978
Minimum Spearman correlation (over all directionality classes) between repeated runs of the consensus scoring algorithm, using varying input, for
each of the four rank aggregation methods. The ﬁrst row shows the correlation when using the same number of permutations for the input GSA
runs, but varying this ﬁxed number between seven different consensus score runs (for each directionality class). The second row shows the results
from randomly selecting the number of permutations for each input GSA run, creating an input with mixed numbers of permutations. This is
repeated 1000 times for each directionality class. The last three rows are based on randomly selecting a percentage of the GSA runs as input, and this
is repeated 1000 times for each directionality class. The results are for the human diabetes data and the 149 Mootha gene sets, similar results for the
S. cerevisiae data set and for the human diabetes data set using GO terms are presented in Supplementary Table S3.
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The reason for using gene set ranks in the result aggre-
gation, rather than the gene set P-values directly, is to give
equal weight to conservative and less conservative
methods. A limitation of this is that it may become difﬁ-
cult to compare the results of different experiments, based
solely on the consensus scores. It should be kept in mind
that a rank of one, only means that this gene set is the
most signiﬁcant; however, it does not per se say anything
about the level of signiﬁcance. Hence, it is important to
evaluate the consensus scores in combination with the
gene set P-values, as described in Figure 5 and
Supplementary Figure S6, to not lose the information
about statistical signiﬁcance. Apart from aggregating the
results of different methods, the consensus scoring
approach can enable the generation of gene set results
for all of the directionality classes (which not all
methods can do on their own). An important issue is the
robustness of the aggregation and we investigated this
with regard to the issue of using GSA results with different
P-value resolutions (derived from the use of different
numbers of permutations during signiﬁcance estimation)
and with regard to randomly choosing a subset of the
GSA results. Reassuringly, in both cases, we show that
the consistency of the consensus scoring is high.
The directionality classiﬁcation aims to give compre-
hensible information on the effect of gene expression
directionality in the context of gene sets, as well as cat-
egorize what kind of directionality information is captured
by the P-values given by different GSA methods. If the
goal is to analyze gene sets without the interest in expres-
sion directionality, the non-directional class is the choice.
If the goal is to incorporate directionality information in
the analysis, the mixed-directional and distinct-directional
classes should be used. The mixed-directional class gives
information on the signiﬁcance of the separate subsets of
up- and downregulated genes in a gene set, disregarding
the relative amount of genes in each of the two subsets.
This can for instance be important for the biological in-
terpretation of large gene sets, experiencing complex regu-
lation with components of regulation in both directions.
The distinct-directional class, on the other hand, incorp-
orates the directionality information on the gene set as
whole to assess whether there is a consolidated signiﬁcance
in one distinct direction. Of course, it is encouraged to use
the combined information given by all three directionality
classes in the interpretation step.
The important point with using the directionality clas-
siﬁcation and consensus scoring is demonstrated by the
three example gene sets (OXPHOS_HG-U133A_probes,
MAP00240_Pyrimidine_metabolism and MAP00910_
Nitrogen_metabolism), as mentioned in the end of the
‘Results’ section. The information given by the combin-
ation of P-values of different directionality classes is
superior of that given by only a single P-value. For
instance, if one would use the mean gene statistic
starting from gene-level t-values (resulting in the
distinct-directional class), the interpretation would be
that nitrogen metabolism is downregulated. However, if
the gene-level P-values were used instead (resulting in the
mixed-directional class), the interpretation would com-
pletely change to that nitrogen metabolism is not
affected at all. These are of course two different results.
The beneﬁt of the directionality classes comes from using
them in combination, to get the whole picture. This can be
achieved by combining the results from different runs of
the GSA workﬂow.
In conclusion, our reﬁned and implemented GSA
workﬂow can be used to analyze gene expression data,
as well as proteomics, metabolomics and genome-wide as-
sociation data. Different methods can easily be run in
parallel, enabling comparison and assessment of the vari-
ation of the results and the possibility of calculating gene
set consensus scores. In combination with the directional-
ity classes, this constitutes a more thorough basis for the
biological interpretation of the gene set results.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables 1–3, Supplementary Figures 1–8
and Supplementary Methods.
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